The new rules will apply to those who wish to spend over six months in the UK and come from a country deemed to have a high incidence of TB.

Medical innovation is not delivering for the needs of people in developing countries. 65th World Health Assembly to debate binding convention on R&D.

Tuberculosis is still one of the most important causes of death worldwide. Perseverance and renewed commitment are needed to achieve global control of tuberculosis, and ultimately, its elimination.

The Division of Tuberculosis Elimination (DTBE), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Office of Infectious Diseases, Centers for Disease Control and Prevention (CDC), is pleased to announce the launch of the Spanish TB website. This website is available at http://www.cdc.gov/tb/esp.

A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bacterial infection.

As of the end of the first quarter of 2012, nearly 864,000 GeneXpert MTB/RIF rapid tuberculosis (TB) diagnostic cartridges had been procured under manufacturer Cephied’s concessional pricing mechanism.

Australia and Vietnam are working together to tackle tuberculosis (TB) in Vietnam, which has one of the highest rates of the disease in Asia.

The House Appropriations Committee voted on its fiscal year (FY) 2013 State and Foreign Operations Appropriations bill Wednesday and released a report that clarifies its funding intentions for key global health programs. 

There haven't been any new TB drugs for over 40 years. But an unlikely partnership between non-profits and a mining company may save thousands of lives in the search for a new vaccine.

"The lives of more than 740,000 people in nine African countries were saved between 2004 and 2008 by the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]," according to a study conducted by Stanford University School of Medicine researchers and published in the Journal of the American Medical Association (JAMA) on Wednesday, HealthDay News reports (3/15). "The study is the first to show a decline in all-cause mortality related to the program," a Stanford press release notes, adding, "To measure the impact of the program, [Eran Bendavid, assistant professor of medicine at Stanford,] and his colleagues analyzed health and survival information for more than 1.5 million adults in 27 African countries, including nine countries where PEPFAR has focused its efforts" (Richter, 5/10). According to the study, "an estimated total of 740,914 all-cause adult deaths were averted between 2004 and 2008 in association with PEPFAR," and "[i]n comparison, PEPFAR was associated with an estimated 631,338 HIV-specific deaths averted during the same period," a JAMA press release states, noting that "all-cause adult mortality declined more in African countries in which ... PEPFAR operated more intensively" (5/15).